Deep Brain Stimulator Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2028

  • Report ID : 100087
  • Category : Medical Devices
  • Pages : -----
  • Reporting status : Published Jan, 19
Allows one Individual to access the Report within an organization
Allows all Employee to access the Report within an organization

Please choose the suitable license type from above.

Buy Now
  • Description
  • Table of Content
  • Research Methodology
  • Related Reports

Deep brain stimulation is a technique that comprises implanting electrodes within specified areas of a patient’s brain. Such electrodes are also known as “brain electrodes” and they emit electrical impulses that regulate abnormal impulses caused by various neurological diseases. The amount of stimulation in this technique is controlled by a device resembling pacemaker that is set beneath the skin on the upper chest of the patient. A connecting wire travels beneath the patient’s skin to the electrodes in the patient’s brain.

Deep brain stimulation (DBS) device is essentially utilized to alleviate symptoms of Parkinson’s disease (PD) as once implanted at one of the three FDA approved brain sites, these electrodes block the electrical signals from these sites to the brain. Namely, Ventrointermedialis (VIM) nucleus of the thalamus, subthalamic nucleus (STN) and globus pallidus pars interna (GPi) are the three FDA approved targeted brain sites for combating Parkinson’s.

One of the most essential factors fuelling DBS market is the increasing cases of Parkinson’s disease. Although there are various surgical options available i.e such as thalamotomy, pallidotomy etc, deep brain stimulation stands as the most widely preferred surgical option owing to the absence of tissue destruction and reversible nature of the surgical treatment. Thus, owing to the fewer complications of this surgical treatment, this market is estimated to grow substantially over the forecast period.  Medtronic’s device Activa PC+S system is a closed-loop DBS device capable of developing an algorithm of the closed-loop system while simultaneously recording the electrical activities in brain. This device is anticipated to be tested positive for a permanent treatment of advanced Parkinson disease. Advent of such devices in the market is projected to benefit patients suffering with Parkinsons, thereby augmenting the deep brain stimulation devices market.

Long term medication which is relatively steep in nature makes treatment of Parkinson and Alzheimer disease extremely unaffordable to a huge section of the population in emerging economies. DBS, on the other hand is a minimally-invasive technology with a long term solution for such chronic ailments. This factor has led to the increased demand for such procedures and devices to aid in the treatment of chronic disease conditions such as blood clot, diabetes, Parkinson’s disease, Alzheimer’s disease and stroke thereby augmenting the deep brain stimulation devices market.

Various novel applications of deep brain stimulation devices particularly for Alzheimer and tinnitus treatment are expected to create new opportunities in the market. Additionally, medical professionals increasingly prefer deep brain stimulation techniques over drug therapy in order to avoid numerous side effects, thereby boosting the demand for global deep brain stimulation devices. However, high cost of devices and increased risk of infection due to implantation of foreign object in the body, battery failure and allergic reaction may constraint the growth of deep brain stimulation device market.

The global deep brain stimulation devices market is segmented into DBS type Application and Geography. On the basis of DBS types, the market is segregated into Subthalamic DBS, Globus Pallidus DBS, Thalamic DBS and Pedunculopontine nucleus DBS. Based on application, the market is bifurcated into pain management, epilepsy, obsessive compulsive disorder (OCD), depression, parkinson disease, essential tremor and dystonia. Geographically, the market is segmented into four regions namely North America, Europe, Asia Pacific, Middle East and Africa and .Latin America.

Some of the major market players have adopted the strategy of acquisition for enhancing the DBS market. For instance, Neurotech has been acquired by Sorin group in order to increase its product portfolio in the DBS market. The companies profiled in this report are Medtronic, Boston Scientific Corporation, Enteromedics, Cyberonics, St. Jude Medical, Neuropace, Zynex, Neuronetics, Functional Neuromodulation, Microtransponder and Neurosigma.

Want to customize this report?

We Can Customize The Report According To Your Need If Listed Report Does Not Meet Your Requirements,Our Research Will Cover All The Businesses Information Required By You.

Please Fill In The Customization Form With Your Requirements.

Help Center

Email Address :

Help Center

Toll Free :+442037693786

More FAQ's